Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1. A second...
Prif Awduron: | Bowerman, M, Becker, C, Yáñez-Muñoz, R, Ning, K, Wood, M, Gillingwater, T, Talbot, K, UK SMA Research Consortium |
---|---|
Fformat: | Journal article |
Cyhoeddwyd: |
Company of Biologists
2017
|
Eitemau Tebyg
-
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
gan: Bowerman, M, et al.
Cyhoeddwyd: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
gan: Melissa Bowerman, et al.
Cyhoeddwyd: (2017-08-01) -
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
gan: Winkelsas, AM, et al.
Cyhoeddwyd: (2021) -
Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
gan: Audrey M. Winkelsas, et al.
Cyhoeddwyd: (2021-03-01) -
SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
gan: Wishart, T, et al.
Cyhoeddwyd: (2010)